Delivery Order SPE2DB22D3004-SPE2DB25FQS42
Award Date
5/15/25
Potential Completion Date
6/6/25
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MEKINIST 2 MG TABLET UU 30S, a prescription medication. The award, valued at $17,757.60, has an ultimate completion date of August 28, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of MEKINIST 2 MG TABLET 30-count bottles. The $8,878.79 firm fixed-price contract has an ultimate completion date of October 7, 2024. Amerisourcebergen, a large pharmaceutical distributor, is the prime contractor and there is no set-aside designation for this award. This delivery order is likely part of a larger indefinite delivery contract (IDC) between Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the provision of MEKINIST 0.5 MG TABLET, a specialty pharmaceutical product. The firm fixed price delivery order has a potential value of $7,769.10 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug MEKINIST 2 MG TABLET UU 30S, with a ceiling value of $16,588.64 and a period of performance through June 2, 2025. The contract is not set aside and was awarded on May 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product MEKINIST 2 MG TABLET UU 30S, with a ceiling value of $19,341.02 and a performance period through June 2, 2025. The contract is designated as a Firm Fixed Price Delivery Order, without any set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $18,371.32 fixed-price award is for the delivery of 4,566,462,969 units of the drug MEKINIST 2 MG Tablet with a completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the award is...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order (SPE2DX15D1022|SPE2DX24FVMPP) valued at $11,468.49 to supply the drug MEKINIST 2 MG TABLET UU 30S. The contract is a firm fixed-price arrangement and does not have a set-aside designation. It is awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen. This contract is likely part of the company's broader Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of MEKINIST 2 MG TABLET pharmaceutical products, with a ceiling value of $17,018.12 and a period of performance through April 22, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MEKINIST 2 MG TABLET, a prescription medication, to support federal healthcare programs. The award has a ceiling value of $15,320.23 and an ultimate completion date of October 7, 2024. This contract is not set aside for any specific business type. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs)...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,341.02 firm fixed-price delivery order is for the supply of 4,568,131,488 units of the medication MEKINIST 2MG TAB 30S. The contract has an ultimate completion date of May 27, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...